Dobutamine primarily targets which receptor?

Dobutamine primarily targets which receptor?

• A. Beta 1 receptors
• B. Alpha 1 receptors
• C. Beta 2 receptors
• D. Dopaminergic receptors

Answer: (A)

Dobutamine mainly stimulates beta-1 adrenergic receptors in the heart. Activating these receptors increases the force of heart muscle contraction, raising stroke volume and cardiac output. This inotropy helps improve perfusion in conditions like heart failure or cardiogenic shock without causing a heavy increase in vascular resistance. There can be some minor activity on other receptors, but the key clinical effect comes from beta-1 stimulation. If it acted primarily on alpha-1 receptors, you’d expect more vasoconstriction and higher afterload; if it targeted dopaminergic receptors or beta-2 receptors, the hemodynamic changes would be different (vasodilation or renal effects rather than the main boost in contractility). So the receptor most responsible for dobutamine’s primary action is beta-1.

Dobutamine mainly stimulates beta-1 adrenergic receptors in the heart. Activating these receptors increases the force of heart muscle contraction, raising stroke volume and cardiac output. This inotropy helps improve perfusion in conditions like heart failure or cardiogenic shock without causing a heavy increase in vascular resistance. There can be some minor activity on other receptors, but the key clinical effect comes from beta-1 stimulation. If it acted primarily on alpha-1 receptors, you’d expect more vasoconstriction and higher afterload; if it targeted dopaminergic receptors or beta-2 receptors, the hemodynamic changes would be different (vasodilation or renal effects rather than the main boost in contractility). So the receptor most responsible for dobutamine’s primary action is beta-1.